Skip to main content
Clinical Trials/ISRCTN10699064
ISRCTN10699064
Active, not recruiting
未知

Characterisation Of caRdiac Disease in adolescents with perinatally-acquired HIV infection in the antiretroviral therapy era

Biomedical Research and Training Institute0 sites120 target enrollmentJune 6, 2022

Overview

Phase
未知
Intervention
Not specified
Conditions
Myocardial disease in adolescents with perinatal HIV and receiving antiretroviral therapy (ART)
Sponsor
Biomedical Research and Training Institute
Enrollment
120
Status
Active, not recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 6, 2022
End Date
June 30, 2024
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Biomedical Research and Training Institute

Eligibility Criteria

Inclusion Criteria

  • 1\. Aged 10\-19 years
  • 2\. Adolescents with HIV taking ART for at least 6 months
  • 3\. Adolescents without HIV for the comparison group

Exclusion Criteria

  • 1\. Contra\-indications to CMR (implantable cardiac devices, pacemakers, and claustrophobia)
  • 2\. Severe renal impairment (defined as an estimated glomerular filtration rate (eGFR) \<30 ml/min)

Outcomes

Primary Outcomes

Not specified

Similar Trials